Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr 26:2023:1969145.
doi: 10.1155/2023/1969145. eCollection 2023.

Diabetes Management and Outcomes among Patients with Type 2 Diabetes Attending a Renal Service

Elizabeth Skalkos  1 , Rohit Rajagopal  2 , David Simmons  1   2
Affiliations

Diabetes Management and Outcomes among Patients with Type 2 Diabetes Attending a Renal Service

Elizabeth Skalkos et al. J Diabetes Res. .

Abstract

Background: Patients with comorbid type 2 diabetes mellitus (T2DM) and renal disease, particularly those treated with insulin, often require complex pharmacological treatment and management of other diabetes complications.

Aims: To assess the achievement of metabolic targets and compare the current management of renal service attenders with insulin- and noninsulin-treated T2DM.

Methods: Single-centre retrospective cross-sectional study involving medical record review of patients with T2DM aged ≥18 years who visited a metropolitan renal outpatient clinic in 2017. Univariable analysis and multivariable logistic regression were used to identify factors associated with insulin treatment.

Results: Among 268 patients (45.5% insulin-treated), mean HbA1c was higher in insulin-treated vs. noninsulin-treated patients (8.0 ± 1.8% (64 mmol/mol) vs. 6.8 ± 1.2% (51 mmol/mol), p < 0.001). Significantly fewer insulin-treated patients had HbA1c ≤ 7.0% (53 mmol/mol; 31.8% vs. 69.3%, p < 0.001). More insulin-treated patients had ischaemic heart disease (46.7% vs. 33.6%, p = 0.028), diabetic foot disease (15.6% vs. 4.8%, p = 0.003), retinopathy (40.2% vs. 11.0%, p < 0.001), and emergency attendance for severe hypoglycaemia (3.8% vs. 0% p = 0.042). Insulin treatment was more associated with chronic kidney disease stages 4-5 (adjusted odds ratio (aOR) 2.41, 95% CI 1.07-5.43), retinopathy (aOR 3.10, 95% CI 1.04-9.27), and podiatry review (aOR 5.06, 95% CI 1.20-21.38). Only 38 (14.2%) individuals were seen by a colocated public multidisciplinary diabetes service in 2017.

Conclusions: Renal clinic attenders with T2DM, particularly if insulin-treated, remained at increased risk of diabetes-related complications, including severe hypoglycaemia, with limited input from the colocated hospital diabetes team. Approaches to increase coordination of diabetes care among renal patients should be investigated.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

Figures

Figure 1
Figure 1
Classification of patients seen by the renal service. T1DM: type 1 diabetes mellitus; T2DM: type 2 diabetes mellitus; NODAT: new-onset diabetes after transplant.
Figure 2
Figure 2
Key diabetes management issues—insulin- vs. noninsulin-treated patients. Insulin treated (black) vs. noninsulin treated (grey) ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001.
See this image and copyright information in PMC

References

    1. Australia and New Zealand Dialysis and Transplant Registry. Incidence of renal replacement therapy for end stage kidney disease . Adelaide: ANZDATA; 2018. https://www.anzdata.org.au/anzdata/
    1. Kidney Disease Improving Global Outcomes Diabetes Work Group. KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease. Kidney International . 2022;102(5S):S1–S127. - PubMed
    1. Bramlage P., Lanzinger S., van Mark G., et al. Patient and disease characteristics of type-2 diabetes patients with or without chronic kidney disease: an analysis of the German DPV and DIVE databases. Cardiovascular Diabetology . 2019;18(1):1–12. doi: 10.1186/s12933-019-0837-x. - DOI - PMC - PubMed
    1. De Cosmo S., Viazzi F., Pacilli A., et al. Achievement of therapeutic targets in patients with diabetes and chronic kidney disease: insights from the Associazione Medici Diabetologi annals initiative. Nephrology, Dialysis, Transplantation . 2015;30(9):1526–1533. doi: 10.1093/ndt/gfv101. - DOI - PubMed
    1. Betônico C. C. R., Titan S. M. O., Correa-Giannella M. L. C., Nery M., Queiroz M. Management of diabetes mellitus in individuals with chronic kidney disease: therapeutic perspectives and glycemic control. Clinics (São Paulo, Brazil) . 2016;71(1):47–53. doi: 10.6061/clinics/2016(01)08. - DOI - PMC - PubMed

MeSH terms